NCT00274274View on ClinicalTrials.gov

Efficacy and Safety of a Fixed or a Flexible Supplementary Insulin Therapy in Type 2 Diabetes

PHASE4CompletedINTERVENTIONAL

Enrollment

373

Participants

Timeline

Start Date

September 30, 2005

Primary Completion Date

November 30, 2006

Study Completion Date

November 30, 2006

Conditions

DiabetesDiabetes Mellitus, Type 2

Interventions

DRUG

insulin detemir

DRUG

insulin aspart

Trial Locations (1)

Unknown

Düsseldorf

Sponsors

Lead Sponsor

Novo Nordisk A/S

All Listed Sponsors

lead

Novo Nordisk A/S

INDUSTRY